Corrigendum to “Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression” [Cancer Lett. 523, (2021), 43–56]
Publication date: Available online 17 November 2026 Source: Cancer Letters Author(s): Cong Li, Shi Qiu, Kun Jin, Xiaonan Zheng, Xianghong Zhou, Di Jin, Binghe Xu, Xun Jin
Corrigendum to “Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression” [Cancer Lett. 523, (2021), 43–56]. // Cancer Letters. – URL: https://www.sciencedirect.com/science/article/pii/S0304383526007214?dgcid=rss_sd_all
Corrigendum to “Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression” [Cancer Lett. 523, (2021), 43–56]. Cancer Letters. https://www.sciencedirect.com/science/article/pii/S0304383526007214?dgcid=rss_sd_all
“Corrigendum to “Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression” [Cancer Lett. 523, (2021), 43–56].” Cancer Letters.
@article{article99845,
title = {Corrigendum to “Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression” [Cancer Lett. 523, (2021), 43–56]},
journal = {Cancer Letters},
url = {https://www.sciencedirect.com/science/article/pii/S0304383526007214?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment